These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 30575920)

  • 1. MiR-152-3p promotes the development of chronic myeloid leukemia by inhibiting p27.
    Wang L; Wang Y; Lin J
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8789-8796. PubMed ID: 30575920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-124-3p/B4GALT1 axis plays an important role in SOCS3-regulated growth and chemo-sensitivity of CML.
    Liu YX; Wang L; Liu WJ; Zhang HT; Xue JH; Zhang ZW; Gao CJ
    J Hematol Oncol; 2016 Aug; 9(1):69. PubMed ID: 27516205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of specific siRNA targeting at bcr-abl fusion gene and its combination with p27 gene clone on chronic myeloid leukemia cell line K562].
    Wang W; DU Y; Lin GQ; Li NN; Sun BZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):606-11. PubMed ID: 20561411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA HAND2-AS1 inhibits proliferation and promotes apoptosis of chronic myeloid leukemia cells by sponging with micRNA-1275.
    Yang JR; Shi MX; Zeng Y
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2103-2111. PubMed ID: 30915755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-582-3p negatively regulates cell proliferation and cell cycle progression in acute myeloid leukemia by targeting cyclin B2.
    Li H; Tian X; Wang P; Huang M; Xu R; Nie T
    Cell Mol Biol Lett; 2019; 24():66. PubMed ID: 31844417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [MiR-124-3p Enhances the Sansitivity of Chronic Myelogenous Leukemia Cell K562-R to Imatinib by Targeting ABCA2].
    Zhang FJ; Cao WJ; Chang FF; Huang FY; Guo JX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):789-796. PubMed ID: 32552937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA MALAT1 promotes cell proliferation and imatinib resistance by sponging miR-328 in chronic myelogenous leukemia.
    Wen F; Cao YX; Luo ZY; Liao P; Lu ZW
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):1-8. PubMed ID: 30366670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-140-5p induces cell apoptosis and decreases Warburg effect in chronic myeloid leukemia by targeting SIX1.
    Nie ZY; Liu XJ; Zhan Y; Liu MH; Zhang XY; Li ZY; Lu YQ; Luo JM; Yang L
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30962263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-199a-3p Overexpression Suppressed Cell Proliferation and Sensitized Chronic Myeloid Leukaemia Cells to Imatinib by Inhibiting mTOR Signalling.
    Liu X; Cui MM; Zhu HZ; Fu PY; Wang GC; Huang L
    Acta Haematol; 2022; 145(5):484-498. PubMed ID: 35313299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The malignancy suppression role of miR-23a by targeting the BCR/ABL oncogene in chromic myeloid leukemia.
    Xishan Z; Xianjun L; Ziying L; Guangxin C; Gang L
    Cancer Gene Ther; 2014 Sep; 21(9):397-404. PubMed ID: 25213664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiRNA-409-5p dysregulation promotes imatinib resistance and disease progression in children with chronic myeloid leukemia.
    Liu YY; Jiao WY; Li T; Bao YY
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8468-8475. PubMed ID: 31646577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-362-5p promotes the malignancy of chronic myelocytic leukaemia via down-regulation of GADD45α.
    Yang P; Ni F; Deng RQ; Qiang G; Zhao H; Yang MZ; Wang XY; Xu YZ; Chen L; Chen DL; Chen ZJ; Kan LX; Wang SY
    Mol Cancer; 2015 Nov; 14():190. PubMed ID: 26545365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [microRNA targeted to chronic myeloid leukemia Bcr-Abl oncogene screen using deacetylase inhibitor].
    Ai ZD; Wu HY; Chen L
    Zhonghua Yi Xue Za Zhi; 2018 Jan; 98(1):46-50. PubMed ID: 29343029
    [No Abstract]   [Full Text] [Related]  

  • 14. Gene therapy for BCR-ABL+ human CML with dual phosphorylation resistant p27Kip1 and stable RNA interference using an EBV vector.
    Sengupta A; Banerjee D; Chandra S; Banerjee S
    J Gene Med; 2006 Oct; 8(10):1251-61. PubMed ID: 16952195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-153-3p enhances the sensitivity of chronic myeloid leukemia cells to imatinib by inhibiting B-cell lymphoma-2-mediated autophagy.
    Li YL; Tang JM; Chen XY; Luo B; Liang GH; Qu Q; Lu ZY
    Hum Cell; 2020 Jul; 33(3):610-618. PubMed ID: 32342278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells.
    Venturini L; Battmer K; Castoldi M; Schultheis B; Hochhaus A; Muckenthaler MU; Ganser A; Eder M; Scherr M
    Blood; 2007 May; 109(10):4399-405. PubMed ID: 17284533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of Lentiviral Vector for miR-217 Overexpression and Knockdown and Its Effect on CML.
    Yang X; Jiang H; Sun C
    Mol Biotechnol; 2023 Aug; 65(8):1253-1262. PubMed ID: 36495416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of miR-144-3p on Proliferation, Cell Cycle and Apoptosis of K562 Cells].
    Kang Y; Hao JX; Wei SH; Wang MC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):76-80. PubMed ID: 36765480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DUXAP10 regulates proliferation and apoptosis of chronic myeloid leukemia via PTEN pathway.
    Yao R; Feng WT; Xu LJ; Zhong XM; Liu H; Sun Y; Zhou LL
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4934-4940. PubMed ID: 30070329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circ_0009910 promotes imatinib resistance through ULK1-induced autophagy by sponging miR-34a-5p in chronic myeloid leukemia.
    Cao HX; Miao CF; Sang LN; Huang YM; Zhang R; Sun L; Jiang ZX
    Life Sci; 2020 Feb; 243():117255. PubMed ID: 31923418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.